用于前列腺癌放射治疗计划的正电子发射断层显像/计算机断层扫描

PET/Computed Tomography for Radiation Therapy Planning of Prostate Cancer.

作者信息

Kairemo Kalevi J A

机构信息

Department of Molecular Radiotherapy, Docrates Cancer Center, Saukonpaadenranta 2, Helsinki FI-00180, Finland; Department of Nuclear Medicine, Docrates Cancer Center, Saukonpaadenranta 2, Helsinki FI-00180, Finland; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA.

出版信息

PET Clin. 2017 Apr;12(2):257-267. doi: 10.1016/j.cpet.2016.12.003. Epub 2017 Jan 31.

DOI:10.1016/j.cpet.2016.12.003

PMID:28267458

Abstract

This article is a short review of PET tracers, which have been used in clinical routine in single institutions. Preliminary anecdotal research supports the use of PET techniques in therapy planning of prostate cancer. The existing literature is discussed. For external beam radiation therapy, the biological target volume definition can only be based on PET imaging. There are not yet any prospective and randomized trials available; therefore, single-institution experiences cannot yet be recommended as clinical routine.

摘要

本文是对已在单一机构临床常规中使用的正电子发射断层扫描（PET）示踪剂的简短综述。初步的轶事性研究支持在前列腺癌治疗计划中使用PET技术。文中讨论了现有文献。对于外照射放疗，生物靶区的定义只能基于PET成像。目前尚无任何前瞻性随机试验；因此，单一机构的经验尚不能推荐作为临床常规。